CELCUITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
CELCUITY INC. (CELC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-13
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-26 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-27 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-23 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-23 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 0.00% 10-K · filed 2021-02-16 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-13 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | 0.00% 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | 0.00% 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-03-01 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | 0.00% 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | 0.00% 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | 0.00% 10-K · filed 2018-03-15 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |